Clinical and Translational Medicine (May 2023)

Correction to: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors

Yinfeng Lyu,
Kunping Li,
Yuqing Li,
Hui Wen,
Chenchen Feng

Affiliations

Yinfeng Lyu: Department of Urology Huashan Hospital Fudan University Shanghai P. R. China
Kunping Li: Department of Urology Huashan Hospital Fudan University Shanghai P. R. China
Yuqing Li: Department of Urology Huashan Hospital Fudan University Shanghai P. R. China
Hui Wen: Department of Urology Huashan Hospital Fudan University Shanghai P. R. China
Chenchen Feng: Department of Urology Huashan Hospital Fudan University Shanghai P. R. China

DOI: https://doi.org/10.1002/ctm2.1268
Journal volume & issue: Vol. 13, no. 5
pp. n/a – n/a

Abstract

No abstracts available.

Published in Clinical and Translational Medicine

ISSN: 2001-1326 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20011326

About the journal